109 related articles for article (PubMed ID: 17158948)
1. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
Sabery N; Bass D
Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
[TBL] [Abstract][Full Text] [Related]
2. Serology and Comorbidities in Patients With Fracture Nonunion: A Multicenter Evaluation of 640 Patients.
Shapiro JA; Stillwagon MR; Tornetta P; Seaver TM; Gage M; O'Donnell J; Whitlock K; Yarboro SR; Jeray KJ; Obremskey WT; Rodriguez-Buitrago A; Matuszewski P; Lin FC; Ostrum RF
J Am Acad Orthop Surg; 2022 Sep; 30(18):e1179-e1187. PubMed ID: 36166389
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: Erythrocyte sedimentation rate test is essential in a subset of patients.
Singh G
Am J Clin Pathol; 2024 Mar; 161(3):311. PubMed ID: 37842812
[No Abstract] [Full Text] [Related]
4. Reply to "C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: erythrocyte sedimentation rate test is essential in a subset of patients".
Shin D; Cho HJ
Am J Clin Pathol; 2024 Mar; 161(3):312. PubMed ID: 37842811
[No Abstract] [Full Text] [Related]
5. Study of erythrocyte sedimentation in human blood through the photoacoustic signals analysis.
Pérez-Pacheco A; Ramírez-Chavarría RG; Colín-García MP; Cortés-Ortegón FDC; Quispe-Siccha RM; Martínez-Tovar A; Olarte-Carrillo I; Polo-Parada L; Gutiérrez-Juárez G
Photoacoustics; 2024 Jun; 37():100599. PubMed ID: 38495950
[TBL] [Abstract][Full Text] [Related]
6. [False positives in infectious serology : a rare issue that should not be ignored].
Dumoulin A
Rev Med Suisse; 2023 Oct; 19(845):1830-1834. PubMed ID: 37819179
[TBL] [Abstract][Full Text] [Related]
7. HLADQA1∗05G>A Genetic Screening Promotes the Safe Delivery of Combination Therapy in Inflammatory Bowel Disease.
Wilson A; Chande N; Ponich T; Gregor JC; Choi YH; Kim RB
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):890-892.e2. PubMed ID: 37730155
[No Abstract] [Full Text] [Related]
8. Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate.
Kucharz EJ
Reumatologia; 2017; 55(1):24-28. PubMed ID: 28386139
[TBL] [Abstract][Full Text] [Related]
9. ERYTHROCYTE SEDIMENTATION RATE - IS THERE A NEED FOR A FASTING BLOOD SAMPLE?
Taneja N
Med J Armed Forces India; 1997 Jan; 53(1):72. PubMed ID: 28769445
[No Abstract] [Full Text] [Related]
10. Reviewing Recommendations for Vaccines and Health Care Maintenance in Patients With Inflammatory Bowel Disease.
Farraye FA
Gastroenterol Hepatol (N Y); 2024 Feb; 20(2):115-118. PubMed ID: 38414913
[No Abstract] [Full Text] [Related]
11. Inflammatory bowel disease in children: finding the best diagnostic tool.
Forero PA; Ortiz AFH; Perdomo AV; Bedoya N
J Ultrasound; 2024 Apr; ():. PubMed ID: 38683472
[No Abstract] [Full Text] [Related]
12. Update to COVID-19 serologic testing : FAQs and caveats.
Kadkhoda K
Cleve Clin J Med; 2022 Jan; ():. PubMed ID: 35022225
[No Abstract] [Full Text] [Related]
13. Shortcomings of the inflammatory bowel disease Serology 7 panel.
Benor S; Russell GH; Silver M; Israel EJ; Yuan Q; Winter HS
Pediatrics; 2010 Jun; 125(6):1230-6. PubMed ID: 20439597
[TBL] [Abstract][Full Text] [Related]
14. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease.
Sakurai T; Saruta M
Digestion; 2023; 104(1):30-41. PubMed ID: 36404714
[TBL] [Abstract][Full Text] [Related]
15. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.
Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY
JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of inflammatory bowel disease in children.
Oliveira SB; Monteiro IM
BMJ; 2017 May; 357():j2083. PubMed ID: 28566467
[TBL] [Abstract][Full Text] [Related]
17. Occult Blood and Perianal Examination: Value Added in Pediatric Inflammatory Bowel Disease Screening.
Moran CJ; Kaplan JL; Winter HS; Masiakos PT
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):52-55. PubMed ID: 25651490
[TBL] [Abstract][Full Text] [Related]
18. Emerging Strategies in the Use of IBD-related Serologic Markers.
Dubinsky MC
Gastroenterol Hepatol (N Y); 2008 Aug; 4(8):557-9. PubMed ID: 21960935
[No Abstract] [Full Text] [Related]
19. Emerging diagnostic methods in inflammatory bowel disease.
Loftus EV
Gastroenterol Hepatol (N Y); 2007 Apr; 3(4):284-6. PubMed ID: 21960842
[No Abstract] [Full Text] [Related]
20. Circulating microRNA is a biomarker of pediatric Crohn disease.
Zahm AM; Thayu M; Hand NJ; Horner A; Leonard MB; Friedman JR
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):26-33. PubMed ID: 21546856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
